Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Other Long-Term Liabilities : ¥69 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co Other Long-Term Liabilities?

Zhejiang Garden Biopharmaceutical Co's other long-term liabilities for the quarter that ended in Mar. 2025 was ¥69 Mil.

Zhejiang Garden Biopharmaceutical Co's quarterly other long-term liabilities declined from Sep. 2024 (¥74 Mil) to Dec. 2024 (¥65 Mil) but then increased from Dec. 2024 (¥65 Mil) to Mar. 2025 (¥69 Mil).

Zhejiang Garden Biopharmaceutical Co's annual other long-term liabilities increased from Dec. 2022 (¥64 Mil) to Dec. 2023 (¥87 Mil) but then declined from Dec. 2023 (¥87 Mil) to Dec. 2024 (¥65 Mil).

Zhejiang Garden Biopharmaceutical Co Other Long-Term Liabilities Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co Other Long-Term Liabilities Chart

Zhejiang Garden Biopharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

112.15

68.92

63.96

87.19

65.31

Zhejiang Garden Biopharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															80.50	77.23	73.71	65.31	69.47

Zhejiang Garden Biopharmaceutical Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Zhejiang Garden Biopharmaceutical Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Zhejiang Garden Biopharmaceutical Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Garden Biopharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018

Website

http://www.hybiotech.com

Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.

Executives

Shao Xu Jun	Director
Liu Xiao Ping	Executives
Shao Qin Xiang	Director
Shao Jun Fang	Director
Liu Jian Gang	Directors, executives
Qian Guo Ping	Executives
Zhu Jian Xing	Supervisors
Yu Quan Heng	Directors, executives, directors
Ma Huan Zheng	Directors, executives
Li Hui Ying	Supervisors
Ma Wen De	Director
Chen Yi	Executives
Gu Yi Kang	Independent director

Zhejiang Garden Biopharmaceutical Co Headlines

No Headlines